Advertisement

The Role of Microbiology Laboratory in Infection Prevention

  • Erin Fortier
  • Nancy Khardori
Chapter

Abstract

Identification of the etiologic agents and assessment of antimicrobial susceptibility patterns of significant bacterial isolates are the two primary responsibilities of microbiology laboratory. The increase of antibiotic resistance has become a serious global issue. Infections caused by drug-resistant bacteria are associated with increased morbidity, mortality, and of course higher healthcare-related costs. Over the past few decades, the inappropriate use of antibiotics has created “superbugs” which once considered a rare find in the Microbiology Laboratory are now seen daily. In any bacterial population, there are a proportion of bacteria with natural resistance to a given antibiotic. If that antibiotic is used for too long or too frequently, the resistant bacteria will selectively reproduce, and a phenotypic resistance to the antibiotic will emerge. It is not the use of the antibiotic but, rather, the misuse that results in resistance [1]. Physicians need to educate their patient on when antibiotics are to be used or not and if prescribed the appropriate use of the antibiotic and how noncompliance will create resistance further down the road. Unfortunately, antibiotic prescribing has become the path of “least resistance” and least time commitment for the medical profession at large.

Keywords

Infection Prevention Microbiology Laboratory Antimicrobial Susceptibility Pattern Hampton Road Barrier Precaution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Davies PDO. Does increased use of antibiotics result in increased antibiotic resistance. Clin Infect Dis. 2004;39:18–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Clinical and Laboratory Standards Institute (CLSI). Analysis and presentation of cumulative antimicrobial susceptibility test data, Approved guideline M39-A2. 2nd ed. Wayne: CLSI; 2006.Google Scholar
  3. 3.
    Hindler JF, Steriling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis. 2007;44:867–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Jenkins SG, Schultz AN. Current concepts in laboratory testing to guide antimicrobial therapy. Mayo Clinic Proc. 2012;87(3):290–308.CrossRefGoogle Scholar
  5. 5.
    Jenkins SG, Jerris RC. Critical assessment of issues applicable to development of antimicrobial susceptibility testing break points. J Clin Microbiol. 2011;49(9 suppl):S5–14.CrossRefGoogle Scholar
  6. 6.
    Curris B. PCR testing to improve patient outcomes and reduce C. difficile associated cost. Mang Infect Control. 2009:94–97.Google Scholar
  7. 7.
    Diekema D, Endona M. Look before you leap: active surveillance for multidrug resistant organisms. Clin Infect Dis. 2007;44(8):1101–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer India 2014

Authors and Affiliations

  1. 1.Bon Secours De Paul Medical CenterNorfolkUSA
  2. 2.Division of Infectious Diseases, Department of Internal MedicineEastern Virginia Medical SchoolNorfolkUSA
  3. 3.Department of Microbiology and Molecular Cell BiologyEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations